Everingham & Kerr, Inc. – Merger & Acquisition Advisors focused on the Lower Middle Market

Daniel R. Everingham

Daniel R. Everingham

Daniel R. Everingham (dre@everkerr.com) joined Everingham & Kerr in 2004. Mr. Everingham has been working with corporations, private equity groups and entrepreneurs on financial and strategic projects including mergers and acquisitions, business valuations and transaction consulting engagements. He actively participates in all aspects of the firm's marketing and transaction activities and plays a crucial role in the success of sell-side and buy-side transactions at Everingham & Kerr.

Mr. Everingham is a Certified Valuation Analyst (CVA), an accreditation issued by the National Association of Certified Valuation Analysts (NACVA) for performing business valuations. Mr. Everingham is a Certified Business Intermediary (CBI), a highly coveted designation awarded by the M&A Source and the recognized symbol of professionalism in the M&A industry. Mr. Everingham is also a Chartered Merger and Acquisition Professional (CMAP), an elite credential issued by the Middle Market Investment Banking Association (MMIBA). To achieve the AVA, CBI, and CMAP designations, individuals must pre-qualify based on experience, submit documentation for board review and then take extensive educational courses, pass the required exams and case studies and continue ongoing education within the industry.

Mr. Everingham is an active member of various professional networking organizations and associations including the M&A Source, the International Business Brokers Association (IBBA), the NACVA, the MMIBA, the Southern New Jersey Chamber of Commerce and the Camden County Regional Chamber of Commerce. He also serves on the advisory board of Sure-BioChem Laboratories, LLC.

Mr. Everingham graduated from Appalachian State University.